Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D7AFK9
|
|||
| Drug Name |
KUR-501
|
|||
| Synonyms |
CMD-501
Click to Show/Hide
|
|||
| Drug Type |
CAR-NKT Cell therapy
|
|||
| Indication | Neuroblastoma [ICD-11: 2D11.2; ICD-9: 194] | Phase 1 | [1] | |
| Company |
Kuur Therapeutics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Ganglioside GD2 (GD2) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Kuur Therapeutics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.